Consistently, ex vivo expanded NKG2D+ CD8+ T cells isolated from myeloma patients were potent at recognizing and killing NKG2DL high expressing allogeneic myeloma cells [24]. The gene discussed is KLRK1; the disease is plasma cell myeloma.